These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 1351025

  • 1. [Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol].
    Wörz R, Reinhardt-Benmalek B, Föh M, Grotemeyer KH, Scharafinski HW.
    Fortschr Med; 1992 May 20; 110(14):268-72. PubMed ID: 1351025
    [Abstract] [Full Text] [Related]

  • 2. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R, Lichtenthal A, Wöhling H, Graf C, Brixius K.
    Headache; 2008 Jan 20; 48(1):118-25. PubMed ID: 18184294
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis.
    Streng A, Linde K, Hoppe A, Pfaffenrath V, Hammes M, Wagenpfeil S, Weidenhammer W, Melchart D.
    Headache; 2006 Jan 20; 46(10):1492-502. PubMed ID: 17115982
    [Abstract] [Full Text] [Related]

  • 4. Central mechanisms of controlled-release metoprolol in migraine: a double-blind, placebo-controlled study.
    Siniatchkin M, Andrasik F, Kropp P, Niederberger U, Strenge H, Averkina N, Lindner V, Stephani U, Gerber WD.
    Cephalalgia; 2007 Sep 20; 27(9):1024-32. PubMed ID: 17680819
    [Abstract] [Full Text] [Related]

  • 5. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P, Thalhofer S, Bethge H, Disselhoff G, Wagner G.
    J Cardiovasc Pharmacol; 1990 Sep 20; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [Abstract] [Full Text] [Related]

  • 6. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
    Brandes JL, Visser WH, Farmer MV, Schuhl AL, Malbecq W, Vrijens F, Lines CR, Reines SA, Protocol 125 study group.
    Headache; 2004 Jun 20; 44(6):581-6. PubMed ID: 15186302
    [Abstract] [Full Text] [Related]

  • 7. [The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus].
    Vulpis V, Antonacci A, Prandi P, Bokor D, Pirrelli A.
    Minerva Med; 1991 Apr 20; 82(4):189-93. PubMed ID: 1673233
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK, Mathew N, Diener HC, Hu P, Haas M, Novak GP, Study Group.
    Headache; 2009 Feb 20; 49(2):216-26. PubMed ID: 19222595
    [Abstract] [Full Text] [Related]

  • 9. Casual versus ambulatory twenty-four-hour blood pressure measurement in a comparative study with bisoprolol or nitrendipine.
    Mengden T, Schubert M, Jeck T, Edmonds D, Vetter W.
    J Hypertens Suppl; 1990 Sep 20; 8(4):S91-4. PubMed ID: 1979615
    [Abstract] [Full Text] [Related]

  • 10. [Comparative study between bisoprolol and metoprolol, combined with hydrochlorothiazide, as antihypertensive therapy].
    Unzueta Montoya A, Unzueta A, Ordóñez Toquero G, Villasis Keever MA, Cocoletzi López J, Medina Santillán R.
    Arch Inst Cardiol Mex; 2000 Sep 20; 70(6):589-95. PubMed ID: 11255718
    [Abstract] [Full Text] [Related]

  • 11. [Beta blockers in migraine prophylaxis].
    Shimizu T.
    Brain Nerve; 2009 Oct 20; 61(10):1125-30. PubMed ID: 19882938
    [Abstract] [Full Text] [Related]

  • 12. Prophylactic treatment of migraine with bisoprolol: a placebo-controlled study.
    van de Ven LL, Franke CL, Koehler PJ.
    Cephalalgia; 1997 Aug 20; 17(5):596-9. PubMed ID: 9251876
    [Abstract] [Full Text] [Related]

  • 13. Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials.
    Diener HC, Scholz E, Dichgans J, Gerber WD, Jäck A, Bille A, Niederberger U.
    Ann Neurol; 1989 Feb 20; 25(2):125-30. PubMed ID: 2645824
    [Abstract] [Full Text] [Related]

  • 14. [Beta-blockers and migraine. Efficacy of time-release propranolol versus placebo].
    Pradalier A, Serratrice G, Collard M, Hirsch E, Feve J, Masson M, Masson C, Dry J, Koulikovsky G, Nguyen G.
    Therapie; 1990 Feb 20; 45(5):441-5. PubMed ID: 2260046
    [Abstract] [Full Text] [Related]

  • 15. [A new beta 1-receptor blocker in the therapy of essential hypertension and angina pectoris].
    Burkart F, Stamm G, Witassek F.
    Schweiz Med Wochenschr; 1989 May 06; 119(18):575-81. PubMed ID: 2568685
    [Abstract] [Full Text] [Related]

  • 16. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr 06; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 17. [Beta-blockers and migraine].
    Massiou H, Bousser MG.
    Pathol Biol (Paris); 1992 Apr 06; 40(4):373-80. PubMed ID: 1353872
    [Abstract] [Full Text] [Related]

  • 18. Selective and non-selective beta-blockers: are both effective in prophylaxis of migraine? A clinical trial versus methysergide.
    Steardo L, Bonuso S, Di Stasio E, Marano E.
    Acta Neurol (Napoli); 1982 Jun 06; 4(3):196-204. PubMed ID: 7136885
    [No Abstract] [Full Text] [Related]

  • 19. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr 06; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 20. Prevention of migraine with olmesartan in patients with hypertension/prehypertension.
    Charles JA, Jotkowitz S, Byrd LH.
    Headache; 2006 Mar 06; 46(3):503-7. PubMed ID: 16618270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.